Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2018

View Archived Issues

TGF-beta inhibition restores regeneration in acute liver injury

Discovery of a druggable target for traumatic brain injury

Sumitomo Dainippon Pharma divulges dopamine D1/D2 and/or 5-HT2A receptor antagonists

Biogen patents nuclear factor erythroid 2-related factor 2 activators

Novel animal model of glaucoma created using tree shrews

New lysine-specific histone demethylase 1A inhibitors identified at Medshine Discovery

Elevated FGF23, a causative factor in the development of renal anemia and iron deficiency

Lilly discovers N-Acetyl-beta-D-glucosaminidase inhibitors

FDA approves Opdivo for metastatic SCLC that has progressed after platinum-based chemotherapy

GlaxoSmithKline describes discovery of DNMT1 inhibitors at fall ACS National Meeting

FDA places partial clinical hold on Study OX1222 of OXi-4503

Target of rapamycin complex 1 inhibition improves immune function in elderly subjects

Immunocore initiates phase I study of IMCnyeso under GSK collaboration

Tumors in brain lead to T cells in bone

Vaccinations initiated in first-in-human trial of novel attenuated Zika vaccine

Let there be no light damage

FDA approves Eylea injection sBLA in wet AMD

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Celleron enrolls first patient in phase Ib/II study of CXD-101 with nivolumab for colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...